Non Steroidal Antiinflammatory Drugs Influence on Heal of Distal Radius Fracture

NCT ID: NCT01567072

Last Updated: 2016-09-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

192 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-04-30

Study Completion Date

2016-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is believed, that Non Steroidal Antiinflammatory Drug (NSAID) drugs slows bone healing, but the knowledge is based only on animal studies, and the results are automatically raised for the people.

Many patients with bone fracture must therefore avoid the formerly so popular and good painkillers, although no clinical trial evidence is, that this medicine is really harmful for patients with fractures.

The purpose of this study is to investigate whether these drugs slows bone healing, and what the relationship is between various bone studies - DEXA scanning, biochemical bone marker tests, radiographic controls and tissue examination of newly formed bone under a microscope. How sensitive and specific, each of the above study methods? If they are just as sensitive, the cheapest of them recommended as a routine investigation on suspicion of bone effects. Furthermore, to compare the benefit (pain-relieving effect, influence on rehabilitation) of these drugs and their possible harmful side effects (affected and delayed bone healing).

The expectation is that the study may contribute to increased knowledge about NSAIDs effect do pain management, rehabilitation and the entire treatment process significantly easier and safer, so that patients recover faster and return to usual activities.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Forearm Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NSAIDs in 7 days

NSAIDs (Ibuprofen) in 7 days

Group Type EXPERIMENTAL

Ibuprofen

Intervention Type DRUG

Treatment with Ibuprofen 600mg 3times a day in 7 days after Colles fracture diagnosis

NSAIDs in 3 days

NSAIDs (Ibuprofen) in the first 3 days and placebo in the last 4 days

Group Type ACTIVE_COMPARATOR

Ibuprofen

Intervention Type DRUG

Treatment with Ibuprofen 600mg 3 times daily in 3 days after´diagnosis - Colles fracture

Placebo

Only placebo in 7 days

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Only placebo treatment instead of NSAID painkillers

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ibuprofen

Treatment with Ibuprofen 600mg 3times a day in 7 days after Colles fracture diagnosis

Intervention Type DRUG

Ibuprofen

Treatment with Ibuprofen 600mg 3 times daily in 3 days after´diagnosis - Colles fracture

Intervention Type DRUG

Placebo

Only placebo treatment instead of NSAID painkillers

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

M01AE01 7 days M01AE01 3 days M01AE01 0 days

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* written acceptance to participate in the study
* immobilisation or reposition or surgery demanding Colles fracture (which needs to be fixed with external fixation).

Exclusion Criteria

* age - younger than 50 years or older than 80 years
* treatment with prednisolon
* NSAIDs - treatment
* previous fracture or surgery at the wrist
* lack of mental and physical capacity to follow studies' instructions
* lack of informed consent
* other diseases can affect bone substance (oncology, endocrine diseases)
* medical contraindications to NSAIDs use
* smoking, alcohol consumption of more than 14 drinks per week
* secondary dislocation of fracture also apply as exclusion criterion.
Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Aarhus

OTHER

Sponsor Role collaborator

Marius Aliuskevicius

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marius Aliuskevicius

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marius Aliuskevicius, Physician

Role: PRINCIPAL_INVESTIGATOR

Aalborg University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Orthopaedic Surgery, Aalborg University Hospital

Aalborg, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

References

Explore related publications, articles, or registry entries linked to this study.

Persson PE, Nilsson OS, Berggren AM. Do non-steroidal anti-inflammatory drugs cause endoprosthetic loosening? A 10-year follow-up of a randomized trial on ibuprofen for prevention of heterotopic ossification after hip arthroplasty. Acta Orthop. 2005 Dec;76(6):735-40. doi: 10.1080/17453670510045309.

Reference Type BACKGROUND
PMID: 16470423 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010-018543-34

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Acute Pain and Inflammation After Surgery
NCT00774540 COMPLETED PHASE4
Duloxetine Tibial Plateau
NCT04639011 WITHDRAWN PHASE4